48 Results | Everything | Search

Product TypeClear Filters

Analytical Chemistry (6)

Biochemicals (48)

Antivirals (7)

Kinase Inhibitors (48)

Abl Family & Bcr-Abl (48)

Activin-like Kinases (ALKs) (1)

Aurora (5)

Dual Specificity Kinases (1)

EGFR/ErbB/HER Family (5)

FAK Family (1)

FGFR Family (5)

HGFR Family (1)

IGF-1R/InsR Family (1)

JAK Family (3)

LRRKs (1)

MAP3Ks (2)

mTOR (1)

Neurotrophin Receptor/Trk Family (3)

p38 MAPK (1)

PDGFR Family (14)

PI3K (1)

RAF (1)

RET (3)

SRC Family (20)

Syk Family (1)

Tec Family (3)

Tie Family (1)

VEGFR Family (7)

Other Non-Receptor Tyrosine Kinases (4)

Other Receptor Tyrosine Kinases (3)

Other Serine/Threonine Kinases (1)

Xenobiotic Metabolites (2)

Natural Products (1)

Small Molecule Modulators (48)

Research AreaClear Filters

Cancer (42)

Cardiovascular System (4)

Cell Biology (13)

Endocrinology & Metabolism (2)

Epigenetics, Transcription, & Translation (1)

Immunology & Inflammation (10)

Infectious Disease (7)

Neuroscience (4)

Xenobiotic Metabolism (2)

ApplicationClear Filters

Mass Spectrometry (6)

Displaying 1 - 25 of 48 Results

Imatinib (mesylate)

An inhibitor of c-Abl, Bcr-Abl, PDGFR, and c-Kit

CAS No. 220127-57-1

Item No. 13139

Formulation: A crystalline solid

Purity: ≥98%

CGP57148B
STI-571

25 mg

$38

Add

50 mg

$72

Add

100 mg

$97

Add

500 mg

$449

Add

1-NA-PP1

Inhibitor of modified ‘analog-sensitive’ kinases

CAS No. 221243-82-9

Item No. 10954

Formulation: A crystalline solid

Purity: ≥98%

1-Naphthyl-PP1
PP1 Analog

1 mg

$26

Add

5 mg

$115

Add

10 mg

$198

Add

50 mg

$789

Add

Dasatinib

An inhibitor of Abl and Src

CAS No. 302962-49-8

Item No. 11498

Formulation: A crystalline solid

Purity: ≥98%

BMS 354825
Sprycel

10 mg

$36

Add

50 mg

$53

Add

100 mg

$88

Add

250 mg

$176

Add

Nilotinib

A Bcr-Abl inhibitor

CAS No. 641571-10-0

Item No. 10010422

Formulation: A crystalline solid

Purity: ≥95%

AMN107

5 mg

$28

Add

10 mg

$41

Add

25 mg

$81

Add

50 mg

$130

Add

Ponatinib

An inhibitor of native and mutant Bcr-Abl

CAS No. 943319-70-8

Item No. 11494

Formulation: A crystalline solid

Purity: ≥98%

AP 24534

1 mg

$32

Add

5 mg

$86

Add

10 mg

$109

Add

Bosutinib

An inhibitor of Src and Abl kinases

CAS No. 380843-75-4

Item No. 12030

Formulation: A crystalline solid

Purity: ≥98%

SKI 606

5 mg

$49

Add

10 mg

$73

Add

50 mg

$283

Add

100 mg

$469

Add

Saracatinib

A dual inhibitor of c-Src and Abl

CAS No. 379231-04-6

Item No. 11497

Formulation: A crystalline solid

Purity: ≥90%

AZD 0530

5 mg

$35

Add

10 mg

$59

Add

25 mg

$119

Add

50 mg

$168

Add

PD 166326

An inhibitor of c-src and certain receptor tyrosine kinases, including c-abl

CAS No. 185039-91-2

Item No. 9000988

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$108

Add

5 mg

$481

Add

10 mg

$856

Add

AT-9283

A broad spectrum kinase inhibitor

CAS No. 896466-04-9

Item No. 11496

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$98

Add

10 mg

$176

Add

25 mg

$318

Add

50 mg

$490

Add

Nilotinib-d₆

An internal standard for the quantification of nilotinib

CAS No. 1268356-17-7

Item No. 19280

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₆)

1 mg

$569

Add

Herbimycin A

An inhibitor of tyrosine kinases and Hsp90

CAS No. 70563-58-5

Item No. 15504

Formulation: A yellow lyophilisate

Purity: ≥95%

Antibiotic TAN 420F
NSC 305978

500 µg

$418

Add

2.5 mg

$1,355

Add

N-desmethyl Imatinib

A major active metabolite of imatinib

CAS No. 404844-02-6

Item No. 16947

Formulation: A lyophilized solid

Purity: ≥95%

N-desmethyl Gleevec
STI-509-00

500 µg

$42

Add

1 mg

$79

Add

5 mg

$303

Add

10 mg

$561

Add

Dasatinib-d₈

An internal standard for the quantification of GC- or LC-MS

CAS No. 1132093-70-9

Item No. 22368

Formulation: A solid

Purity: ≥99% deuterated forms (d₁d₈); ≤1% d₀

Sprycel-d₈

500 µg

$125

Add

1 mg

$236

Add

AST-487

A multi-kinase inhibitor

CAS No. 630124-46-8

Item No. 19477

Formulation: A crystalline solid

Purity: ≥98%

NVP-AST-487

1 mg

$37

Add

5 mg

$124

Add

10 mg

$229

Add

25 mg

$523

Add

Asciminib

An allosteric inhibitor of Abl1

CAS No. 1492952-76-7

Item No. 26126

Formulation: A crystalline solid

Purity: ≥95%

ABL001

1 mg

$69

Add

5 mg

$280

Add

10 mg

$525

Add

Danusertib

A pan-Aurora kinase and Abl inhibitor

CAS No. 827318-97-8

Item No. 18387

Formulation: A crystalline solid

Purity: ≥95%

PHA-739358

1 mg

$42

Add

5 mg

$147

Add

10 mg

$230

Add

50 mg

$627

Add

ALW-II-41-27

A multi-kinase inhibitor

CAS No. 1186206-79-0

Item No. 25275

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$69

Add

5 mg

$297

Add

10 mg

$525

Add

Imatinib-d₃

An internal standard for the quantification of imatinib

CAS No. 1134803-18-1

Item No. 18257

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₃)

Genfatinib-d₃

500 µg

$112

Add

1 mg

$202

Add

CZC-8004

A tyrosine kinase inhibitor

CAS No. 916603-07-1

Item No. 16718

Formulation: A crystalline solid

Purity: ≥98%

Dianilinopyrimidine-01

500 µg

$90

Add

1 mg

$158

Add

5 mg

$436

Add

10 mg

$696

Add

GZD-824

A Bcr/Abl inhibitor

CAS No. 1257628-77-5

Item No. 21508

Formulation: A crystalline solid

Purity: ≥98%

HQP1351
Olverembatinib

1 mg

$36

Add

5 mg

$153

Add

10 mg

$268

Add

25 mg

$502

Add

Ponatinib-d₈

An internal standard for the quantification of ponatinib

CAS No. 1562993-37-6

Item No. 28905

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₈)

1 mg

$390

Add

Radotinib

A selective Bcr-Abl tyrosine kinase inhibitor

CAS No. 926037-48-1

Item No. 19923

Formulation: A crystalline solid

Purity: ≥98%

IY-5511

1 mg

$36

Add

5 mg

$120

Add

10 mg

$203

Add

25 mg

$378

Add

MGCD-265

A c-Met and VEGFR2 inhibitor

CAS No. 875337-44-3

Item No. 20097

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$48

Add

5 mg

$190

Add

10 mg

$355

Add

25 mg

$708

Add

Bafetinib

A Bcr-Abl inhibitor

CAS No. 859212-16-1

Item No. 19169

Formulation: A crystalline solid

Purity: ≥95%

INNO-406
NS-187

1 mg

$49

Add

5 mg

$130

Add

10 mg

$236

Add

KW 2449

A multi-kinase inhibitor

CAS No. 1000669-72-6

Item No. 22207

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$36

Add

10 mg

$64

Add

25 mg

$150

Add

50 mg

$264

Add

Displaying 1 - 25 of 48 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥90%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d6)

Formulation: A yellow lyophilisate

Purity: ≥95%

Formulation: A lyophilized solid

Purity: ≥95%

Formulation: A solid

Purity: ≥99% deuterated forms (d1d8); ≤1% d0

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d3)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d8)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Purity: ≥99% deuterated forms (d₁-d₆)

Purity: ≥99% deuterated forms (d₁d₈); ≤1% d₀

Purity: ≥99% deuterated forms (d₁-d₃)

Purity: ≥99% deuterated forms (d₁-d₈)